Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1.
Identifieur interne : 005D53 ( PubMed/Curation ); précédent : 005D52; suivant : 005D54Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1.
Auteurs : G J Schuurkamp [Papouasie-Nouvelle-Guinée] ; R K Kereu ; P K BulungolSource :
- Papua and New Guinea medical journal [ 0031-1480 ] ; 1990.
Descripteurs français
- KwdFr :
- Adulte, Animaux, Contrôle des maladies contagieuses, Diéthylcarbamazine (pharmacologie), Diéthylcarbamazine (usage thérapeutique), Femelle, Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Incidence, Mâle, Nouvelle-Guinée, Paludisme (), Paludisme (épidémiologie), Prévalence, Vecteurs insectes (), Wuchereria bancrofti.
- MESH :
- pharmacologie : Diéthylcarbamazine.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Diéthylcarbamazine.
- épidémiologie : Filariose lymphatique, Paludisme.
- Adulte, Animaux, Contrôle des maladies contagieuses, Femelle, Filariose lymphatique, Humains, Incidence, Mâle, Nouvelle-Guinée, Paludisme, Prévalence, Vecteurs insectes, Wuchereria bancrofti.
English descriptors
- KwdEn :
- Adult, Animals, Communicable Disease Control, Diethylcarbamazine (pharmacology), Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Female, Humans, Incidence, Insect Vectors (drug effects), Malaria (epidemiology), Malaria (prevention & control), Male, New Guinea, Prevalence, Wuchereria bancrofti.
- MESH :
- chemical , pharmacology : Diethylcarbamazine.
- chemical , therapeutic use : Diethylcarbamazine.
- geographic : New Guinea.
- drug effects : Insect Vectors.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial, Malaria.
- prevention & control : Elephantiasis, Filarial, Malaria.
- Adult, Animals, Communicable Disease Control, Female, Humans, Incidence, Male, Prevalence, Wuchereria bancrofti.
Abstract
The effects of a well-spaced diethylcarbamazine (DEC) mass drug application in areas highly endemic for Wuchereria bancrofti in Papua New Guinea are not known. In 1986 a semi-annual single-dose 6 mg/kg body weight administration of DEC was initiated in the Ok Tedi area of Western Province, Papua New Guinea. The rate of bancroftian filariasis in the area was 39%. Within two years the rate of detectable microfilaraemia was reduced from 31% to 11% in the treated group. The mean blood density of the parasite was reduced from 79 to 19 microfilariae per 20 microliters. A survey of untreated villages in the immediate area (not surveyed before 1988) showed a filariasis rate of 39%. A 14-fold difference in the total microfilaraemia count was noted between the two groups when 1988 data were compared. A reduction in the annual rate of filariasis may be monitored through a well-established passive case detection program for malaria. The DEC treatment program was well accepted despite side-effects encountered in 20% of the treated population early on in the program. The success of the 2-year Phase 1 program has expanded into an annual single-dose administration of DEC over a larger area.
PubMed: 2238834
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005D53
Links to Exploration step
pubmed:2238834Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1.</title>
<author><name sortKey="Schuurkamp, G J" sort="Schuurkamp, G J" uniqKey="Schuurkamp G" first="G J" last="Schuurkamp">G J Schuurkamp</name>
<affiliation wicri:level="1"><nlm:affiliation>Ok Tedi Mining Limited, Tabubil, Papua New Guinea.</nlm:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Ok Tedi Mining Limited, Tabubil</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kereu, R K" sort="Kereu, R K" uniqKey="Kereu R" first="R K" last="Kereu">R K Kereu</name>
</author>
<author><name sortKey="Bulungol, P K" sort="Bulungol, P K" uniqKey="Bulungol P" first="P K" last="Bulungol">P K Bulungol</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1990">1990</date>
<idno type="RBID">pubmed:2238834</idno>
<idno type="pmid">2238834</idno>
<idno type="wicri:Area/PubMed/Corpus">005D53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005D53</idno>
<idno type="wicri:Area/PubMed/Curation">005D53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005D53</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1.</title>
<author><name sortKey="Schuurkamp, G J" sort="Schuurkamp, G J" uniqKey="Schuurkamp G" first="G J" last="Schuurkamp">G J Schuurkamp</name>
<affiliation wicri:level="1"><nlm:affiliation>Ok Tedi Mining Limited, Tabubil, Papua New Guinea.</nlm:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Ok Tedi Mining Limited, Tabubil</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kereu, R K" sort="Kereu, R K" uniqKey="Kereu R" first="R K" last="Kereu">R K Kereu</name>
</author>
<author><name sortKey="Bulungol, P K" sort="Bulungol, P K" uniqKey="Bulungol P" first="P K" last="Bulungol">P K Bulungol</name>
</author>
</analytic>
<series><title level="j">Papua and New Guinea medical journal</title>
<idno type="ISSN">0031-1480</idno>
<imprint><date when="1990" type="published">1990</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Animals</term>
<term>Communicable Disease Control</term>
<term>Diethylcarbamazine (pharmacology)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Insect Vectors (drug effects)</term>
<term>Malaria (epidemiology)</term>
<term>Malaria (prevention & control)</term>
<term>Male</term>
<term>New Guinea</term>
<term>Prevalence</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Animaux</term>
<term>Contrôle des maladies contagieuses</term>
<term>Diéthylcarbamazine (pharmacologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Femelle</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Incidence</term>
<term>Mâle</term>
<term>Nouvelle-Guinée</term>
<term>Paludisme ()</term>
<term>Paludisme (épidémiologie)</term>
<term>Prévalence</term>
<term>Vecteurs insectes ()</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>New Guinea</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Insect Vectors</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Malaria</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Malaria</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Paludisme</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Animals</term>
<term>Communicable Disease Control</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Prevalence</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Animaux</term>
<term>Contrôle des maladies contagieuses</term>
<term>Femelle</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Incidence</term>
<term>Mâle</term>
<term>Nouvelle-Guinée</term>
<term>Paludisme</term>
<term>Prévalence</term>
<term>Vecteurs insectes</term>
<term>Wuchereria bancrofti</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effects of a well-spaced diethylcarbamazine (DEC) mass drug application in areas highly endemic for Wuchereria bancrofti in Papua New Guinea are not known. In 1986 a semi-annual single-dose 6 mg/kg body weight administration of DEC was initiated in the Ok Tedi area of Western Province, Papua New Guinea. The rate of bancroftian filariasis in the area was 39%. Within two years the rate of detectable microfilaraemia was reduced from 31% to 11% in the treated group. The mean blood density of the parasite was reduced from 79 to 19 microfilariae per 20 microliters. A survey of untreated villages in the immediate area (not surveyed before 1988) showed a filariasis rate of 39%. A 14-fold difference in the total microfilaraemia count was noted between the two groups when 1988 data were compared. A reduction in the annual rate of filariasis may be monitored through a well-established passive case detection program for malaria. The DEC treatment program was well accepted despite side-effects encountered in 20% of the treated population early on in the program. The success of the 2-year Phase 1 program has expanded into an annual single-dose administration of DEC over a larger area.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2238834</PMID>
<DateCreated><Year>1990</Year>
<Month>12</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted><Year>1990</Year>
<Month>12</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0031-1480</ISSN>
<JournalIssue CitedMedium="Print"><Volume>33</Volume>
<Issue>2</Issue>
<PubDate><Year>1990</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Papua and New Guinea medical journal</Title>
<ISOAbbreviation>P N G Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1.</ArticleTitle>
<Pagination><MedlinePgn>89-98</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The effects of a well-spaced diethylcarbamazine (DEC) mass drug application in areas highly endemic for Wuchereria bancrofti in Papua New Guinea are not known. In 1986 a semi-annual single-dose 6 mg/kg body weight administration of DEC was initiated in the Ok Tedi area of Western Province, Papua New Guinea. The rate of bancroftian filariasis in the area was 39%. Within two years the rate of detectable microfilaraemia was reduced from 31% to 11% in the treated group. The mean blood density of the parasite was reduced from 79 to 19 microfilariae per 20 microliters. A survey of untreated villages in the immediate area (not surveyed before 1988) showed a filariasis rate of 39%. A 14-fold difference in the total microfilaraemia count was noted between the two groups when 1988 data were compared. A reduction in the annual rate of filariasis may be monitored through a well-established passive case detection program for malaria. The DEC treatment program was well accepted despite side-effects encountered in 20% of the treated population early on in the program. The success of the 2-year Phase 1 program has expanded into an annual single-dose administration of DEC over a larger area.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuurkamp</LastName>
<ForeName>G J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo><Affiliation>Ok Tedi Mining Limited, Tabubil, Papua New Guinea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kereu</LastName>
<ForeName>R K</ForeName>
<Initials>RK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bulungol</LastName>
<ForeName>P K</ForeName>
<Initials>PK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Papua New Guinea</Country>
<MedlineTA>P N G Med J</MedlineTA>
<NlmUniqueID>0376417</NlmUniqueID>
<ISSNLinking>0031-1480</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007303" MajorTopicYN="N">Insect Vectors</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009512" MajorTopicYN="N" Type="Geographic">New Guinea</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014958" MajorTopicYN="Y">Wuchereria bancrofti</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year>
<Month>6</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1990</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1990</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">2238834</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005D53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 005D53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:2238834 |texte= Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:2238834" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |